Literature DB >> 9377534

A behavioural test to assess daytime sleepiness in obstructive sleep apnoea.

L S Bennett1, J R Stradling, R J Davies.   

Abstract

Daytime sleepiness is an important symptom of obstructive sleep apnoea syndrome (OSAS). The standard tests for its objective quantification use EEG recordings, and are time consuming and expensive, which makes them difficult to use for large studies. This study assesses the ability of a simple test of sustained 'wakefulness' to discriminate the excessive somnolence of severe symptomatic obstructive sleep apnoea from normality, and compares its results to the traditional EEG based Maintenance of Wakefulness Test (MWT). Ten subjects (7M 3F) with severe sleep apnoea (> 4% SaO2 dip rate median 32.7 (90% central range 9.7-65.6)) and symptoms of daytime sleepiness, (Epworth Sleepiness Score (ESS)17(10-24)) and 10 normal subjects (4M 6F, ESS 3.5(1-8)) were studied. The MWT and the behavioural test (Oxford SLEep Resistance test - OSLER test) were performed on each subject in random order on 2 separate days. The protocol for both tests was the same with 4 X 40 min sleep resistance challenges throughout the day while sound isolated in a darkened room. During the OSLER test subjects were asked to press a switch in response to a light emitting diode (LED), which was lit for 1 s in every three. Both the switch and the light were connected to a computer that stored both the number of times the light was illuminated and whether a correct response was made. The OSLER test discriminated the normal subjects from the sleep apnoea group (mean sleep latency (min) normal group 39.8, OSA group 10.5) as well as the traditional MWT (normal group 38.1 OSA group 7.3) and was much simpler to administer. This test has the advantage that sleep onset is defined objectively and automatically as a failure to respond to the light, rather than from EEG interpretation, which is inevitable partly subjective. This technique may provide a simple and robust method of objectively quantifying daytime sleepiness for large studies.

Entities:  

Mesh:

Year:  1997        PMID: 9377534     DOI: 10.1046/j.1365-2869.1997.00039.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  34 in total

Review 1.  Pulse transit time: an appraisal of potential clinical applications.

Authors:  R P Smith; J Argod; J L Pépin; P A Lévy
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 2.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

3.  Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials.

Authors:  G V Robinson; J C T Pepperell; H C Segal; R J O Davies; J R Stradling
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

Review 4.  Sleep . 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome.

Authors:  D Schlosshan; M W Elliott
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

5.  The Oxford Sleep Resistance test (OSLER) and the Multiple Unprepared Reaction Time Test (MURT) detect vigilance modifications in sleep apnea patients.

Authors:  Anniina Alakuijala; Paula Maasilta; Adel Bachour
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

6.  The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure.

Authors:  Neil R Ward; Vitor Roldao; Martin R Cowie; Stuart D Rosen; Theresa A McDonagh; Anita K Simonds; Mary J Morrell
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

7.  Randomized controlled trial of variable-pressure versus fixed-pressure continuous positive airway pressure (CPAP) treatment for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS).

Authors:  Marjorie Vennelle; Sandra White; Renata L Riha; Tom W Mackay; Heather M Engleman; Neil J Douglas
Journal:  Sleep       Date:  2010-02       Impact factor: 5.849

Review 8.  Vigilance, alertness, or sustained attention: physiological basis and measurement.

Authors:  B S Oken; M C Salinsky; S M Elsas
Journal:  Clin Neurophysiol       Date:  2006-04-03       Impact factor: 3.708

9.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.

Authors:  Sophie D West; Debby J Nicoll; Tara M Wallace; David R Matthews; John R Stradling
Journal:  Thorax       Date:  2007-06-08       Impact factor: 9.139

Review 10.  Diagnostic approaches to respiratory sleep disorders.

Authors:  Renata L Riha
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.